Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126747281 | 12674728 | 1 | I | 20160411 | 20160818 | 20160822 | 20160822 | EXP | FR-ELI_LILLY_AND_COMPANY-FR201608009246 | ELI LILLY AND CO | 69.51 | YR | M | Y | 0.00000 | 20160822 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126747281 | 12674728 | 1 | PS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | 955 MG, CYCLICAL | Y | U | 21462 | 955 | MG | ||||||
| 126747281 | 12674728 | 2 | SS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | 950 MG, CYCLICAL | Y | U | 21462 | 950 | MG | ||||||
| 126747281 | 12674728 | 3 | SS | ALIMTA | PEMETREXED DISODIUM | 1 | Intravenous (not otherwise specified) | 760 MG, CYCLICAL | Y | U | 21462 | 760 | MG | ||||||
| 126747281 | 12674728 | 4 | SS | CISPLATINE | CISPLATIN | 1 | Intravenous (not otherwise specified) | 145 MG, CYCLICAL | Y | 0 | 145 | MG | |||||||
| 126747281 | 12674728 | 5 | SS | CISPLATINE | CISPLATIN | 1 | Intravenous (not otherwise specified) | 110 MG, CYCLICAL | Y | 0 | 110 | MG | |||||||
| 126747281 | 12674728 | 6 | SS | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 1 DF, 3/W | Y | 0 | 1 | DF | TIW | ||||||
| 126747281 | 12674728 | 7 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126747281 | 12674728 | 8 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126747281 | 12674728 | 9 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126747281 | 12674728 | 10 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126747281 | 12674728 | 11 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126747281 | 12674728 | 12 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126747281 | 12674728 | 13 | C | CORTANCYL | PREDNISONE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126747281 | 12674728 | 14 | C | BETNEVAL | BETAMETHASONE VALERATE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126747281 | 12674728 | 15 | C | STILNOX | ZOLPIDEM TARTRATE | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126747281 | 12674728 | 16 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK, UNKNOWN | U | 0 | |||||||||
| 126747281 | 12674728 | 17 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126747281 | 12674728 | 1 | Lung neoplasm malignant |
| 126747281 | 12674728 | 4 | Lung neoplasm malignant |
| 126747281 | 12674728 | 6 | Prophylaxis |
| 126747281 | 12674728 | 7 | Product used for unknown indication |
| 126747281 | 12674728 | 8 | Product used for unknown indication |
| 126747281 | 12674728 | 9 | Product used for unknown indication |
| 126747281 | 12674728 | 10 | Product used for unknown indication |
| 126747281 | 12674728 | 11 | Product used for unknown indication |
| 126747281 | 12674728 | 12 | Product used for unknown indication |
| 126747281 | 12674728 | 13 | Product used for unknown indication |
| 126747281 | 12674728 | 14 | Product used for unknown indication |
| 126747281 | 12674728 | 15 | Product used for unknown indication |
| 126747281 | 12674728 | 16 | Product used for unknown indication |
| 126747281 | 12674728 | 17 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126747281 | 12674728 | HO |
| 126747281 | 12674728 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126747281 | 12674728 | Hepatitis cholestatic | |
| 126747281 | 12674728 | Malignant neoplasm progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126747281 | 12674728 | 1 | 20160209 | 20160209 | 0 | |
| 126747281 | 12674728 | 2 | 20160301 | 20160301 | 0 | |
| 126747281 | 12674728 | 3 | 20160322 | 20160322 | 0 | |
| 126747281 | 12674728 | 4 | 20160209 | 20160301 | 0 | |
| 126747281 | 12674728 | 5 | 20160322 | 20160322 | 0 | |
| 126747281 | 12674728 | 6 | 201512 | 20160501 | 0 |